Conventional medical cancer screening methods are costly, labor-intensive, and extremely difficult to scale. Although AI can improve cancer detection, most systems rely on complex or specialized medical data, making them impractical for large-scale screening. We introduce Can-SAVE, a lightweight AI system that ranks population-wide cancer risks solely based on medical history events. By integrating survival model outputs into a gradient-boosting framework, our approach detects subtle, long-term patient risk patterns – often well before clinical symptoms manifest. Can-SAVE was rigorously evaluated on a real-world dataset of 2.5 million adults spanning five Russian regions, marking the study as one of the largest and most comprehensive deployments of AI-driven cancer risk assessment. In a retrospective oncologist-supervised study over 1.9M patients, Can-SAVE achieves a 3.8-9.9x higher detection rate at identical screening volumes and an Average Precision (AP) of 0.228 vs. 0.193 for the best baseline (LoRA-tuned Qwen3-Embeddings via DeepSeek-R1 summarization). In a year-long prospective pilot (426K patients), our method almost doubled the cancer detection rate (+91%) and increased population coverage by 36% over the national screening protocol. The system demonstrates practical scalability: a city-wide population of 1 million patients can be processed in under three hours using standard hardware, enabling seamless clinical integration. This work proves that Can-SAVE achieves nationally significant cancer detection improvements while adhering to real-world public healthcare constraints, offering immediate clinical utility and a replicable framework for population-wide screening. Code for training and feature engineering is available at https://github.com/sb-ai-lab/Can-SAVE.

Clinical Decision Support Systems (CDSS) play an increasingly important role in medical diagnostics. We present AI Diagnostic Assistant (AIDA), a real-time predictive model designed to assist doctors in interpreting patient conditions. AIDA analyzes electronic health records (EHR), including medical history, laboratory results, and complaints, to suggest potential diagnoses from 95 common conditions before the doctor makes the final decision. The model acts as a verification and backup tool, ensuring that no critical details are overlooked. Trained on 1.5 million patient records and validated on a dataset curated by a panel of experts, AIDA proves trustworthy as a diagnosis-making assistant (87.7% accuracy compared to 91.7% accuracy among doctors). Integrated into a megapolis-wide CDSS, AIDA has assisted doctors in over 3 million real-world diagnoses to date.

The paper researches the problem of representation learning for electronic health records. We present the patient histories as temporal sequences of diseases for which embeddings are learned in an unsupervised setup with a transformer-based neural network model. Additionally the embedding space includes demographic parameters which allow the creation of generalized patient profiles and successful transfer of medical knowledge to other domains. The training of such a medical profile model has been performed on a dataset of more than one million patients. Detailed model analysis and its comparison with the state-of-the-art method show its clear advantage in the diagnosis prediction task. Further, we show two applications based on the developed profile model. First, a novel Harbinger Disease Discovery method allowing to reveal disease associated hypotheses and potentially are beneficial in the design of epidemiological studies. Second, the patient embeddings extracted from the profile model applied to the insurance scoring task allow significant improvement in the performance metrics.

Medical data annotation requires highly qualified expertise. Despite the efforts devoted to medical entity linking in different languages, available data is very sparse in terms of both data volume and languages. In this work, we establish benchmarks for cross-lingual medical entity linking using clinical reports, clinical guidelines, and medical research papers. We present a test set filtering procedure designed to analyze the “hard cases” of entity linking approaching zero-shot cross-lingual transfer learning, evaluate state-of-the-art models, and draw several interesting conclusions based on our evaluation results.